Learn More
Medchemexpress LLC Tegoprazan | 942195-55-3 | 99.8% | 387.38 | 100 MG

Supplier: Medchemexpress LLC HY17623100MG
Tegoprazan is a potassium-competitive acid blocker, a reversible, orally active, and highly selective inhibitor of gastric H+/K+-ATPase. It inhibits gastric acid secretion and motility against porcine, canine, and human H+/K+-ATPase with IC50 values ranging from 0.29-0.52 μM in vitro. It also significantly improves colitis and enhances the intestinal epithelial barrier function in mice, making it promising for research of inflammatory bowel, gastric acid-related, and motility-impaired diseases.
- Reversible, orally active, and highly selective inhibitor of gastric H+/K+-ATPase.
- Inhibits gastric acid secretion and motility.
- Improves colitis and enhances intestinal epithelial barrier function.
- Promising for research of inflammatory bowel, gastric acid-related, and motility-impaired diseases.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.